Boston Scientific Corp (NYSE:BSX)
| 43.60 Delayed Data As of Jun 21 |  +0.58 / +1.35%Today’s Change | 32.99 Today|||52-Week Range 44.63 | +21.28% Year-to-Date |
Latest BSX News | Press Releases
| Cardiology Space Gains Momentum in 2021: 5 Stocks to Focus on Jun 18 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 43.02 |
| Today’s open | 43.30 |
| Day’s range | 43.17 - 43.82 |
| Volume | 262 |
| Average volume (3 months) | 7,647,176 |
| Market cap | $61.1B |
Data as of 4:54pm ET, 06/21/2021
Growth & Valuation
| Earnings growth (last year) | -102.40% |
| Earnings growth (this year) | +65.04% |
| Earnings growth (next 5 years) | +11.50% |
| Revenue growth (last year) | -7.66% |
| P/E ratio | 16.7 |
| Price/Sales | 5.14 |
| Price/Book | 3.98 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BDXBecton Dickinson and... | -0.09 | -0.04% |
| BAXBaxter International... | +0.69 | +0.85% |
| ZBHZimmer Biomet Holdin... | -0.04 | -0.02% |
| DXCMDexcom Inc | +4.74 | +1.13% |
Data as of 4:00pm ET, 06/21/2021
Financials
| Next reporting date | July 29, 2021 |
| EPS forecast (this quarter) | $0.37 |
| Annual revenue (last year) | $9.9B |
| Annual profit (last year) | -$82.0M |
| Net profit margin | -0.83% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Marlborough, Massachusetts |
Forecasts
